Item |
Information |
Drug Groups
|
approved |
Description
|
An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis. [PubChem] |
Indication |
Used in the treatment of rheumatoid arthritis. |
Pharmacology |
Niflumic acid, a nonsteroidal anti-inflammatory fenamate, is a Ca2+-activated Cl- channel blocker. |
Toxicity |
Oral, mouse: LD50 = 350 mg/kg; Oral, rat: LD50 = 250 mg/kg |
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Hepatic. |
Absorption |
Well absorbed following oral administration. |
Half Life |
2.5 hours |
Protein Binding |
90% bound to plasma proteins. |
References |
• |
Criddle DN, de Moura RS, Greenwood IA, Large WA: Inhibitory action of niflumic acid on noradrenaline- and 5-hydroxytryptamine-induced pressor responses in the isolated mesenteric vascular bed of the rat. Br J Pharmacol. 1997 Mar;120(5):813-8.
[Pubmed]
|
|